Lupin launches Mycophenolic Acid Delayed-Release Tablets USP
Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg, is the generic equivalent of Myfortic Delayed-Release Tablets,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Myfortic
Lupin’s partner Concord gets US FDA nod to market Myfortic tablet
The tablets are indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants Lupin said its…